Nutrition and immunotherapy for advanced stomach and esophagus cancer
Part of Cancer, Digestive system clinical trials.
This trial looks at how your nutrition status affects the success of immunotherapy drugs in people with advanced esophageal squamous cell cancer or stomach adenocarcinoma that has spread. It aims to find if better nutrition leads to better treatment results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with esophageal squamous cell cancer or stomach adenocarcinoma that has spread to other parts of the body.
- You have tumors that can be measured on a CT scan or MRI (at least 1 cm with special scans or 2 cm with a regular CT).
- You are able to do most daily activities on your own (Karnofsky score of 80% or higher).
- Your doctor expects you to live at least 3 more months.
- Your blood counts and liver and kidney function are within certain limits as checked within 2 weeks of starting the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether intensive nutritional support helps patients with advanced esophageal cancer (a type of squamous cell carcinoma) respond better to treatment before surgery. The goal is to improve how well the cancer shrinks and prepare the body for a successful operation.
This trial compares two chemotherapy combinations, with or without an immunotherapy drug called nivolumab, for people with advanced stomach, esophagus, or gastroesophageal junction cancer that cannot be removed by surgery. The goal is to see which treatment works better and if adding immunotherapy helps.
This trial combines an immunotherapy drug (a PD-1 inhibitor) with radiation therapy and special nutrition drinks to treat esophageal cancer that cannot be removed with surgery. The goal is to see if this combination is safe and effective in helping patients live longer and feel better.
This trial tests whether intensive nutritional support helps people with esophageal cancer who are receiving treatment before surgery. You might benefit from this trial if you need extra nutrition during your cancer treatment.
This trial studies whether adding an “immunonutrition” nutrition plan to standard chemoradiation can improve outcomes for people with locally advanced, unresectable esophageal squamous cell cancer. It may help the treatment work better by supporting the immune system during therapy.
This trial tests different combinations of treatments given before surgery for a type of esophageal cancer called squamous cell carcinoma. It aims to find the best approach to shrink the tumor and improve outcomes for patients whose cancer has not spread to distant organs.
Hear when a new Gastric Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.